Background Hepatic metastases develop in approximately 50% of colorectal cancer (CRC)
cases. We performed a review and meta-analysis to evaluate survival after resection of CRC …

Background Chemotherapy-associated liver injury is a major cause for concern when
treating patients with colorectal liver metastases. The aim of this review was to determine the …

Liver resection offers the only chance of cure for patients with advanced colorectal cancer
(CRC). Typically, the 5-year survival rates following liver resection range from 25% to 40 …

Background Selected patients with unresectable colorectal liver metastases (CLM) may be
rendered resectable after systemic chemotherapy. We reviewed the evidence of downsizing …

BACKGROUND: To determine the role of liver resection in patients with liver and
extrahepatic colorectal cancer metastases and the role of chemotherapy in patients in …

Background Ionic liquid (IL) pretreatment could enable an economically viable route to
produce biofuels by providing efficient means to extract sugars and lignin from …

Background Hepatectomy is standard treatment for colorectal liver metastases; however, it is
unclear whether liver metastases from other primary cancers should be resected or not. The …

Questions: 1. Should surgery be considered for colorectal cancer (crc) patients who have
liver metastases plus (a) pulmonary metastases,(b) portal nodal disease, or (c) other …

Background Preoperative chemotherapy containing oxaliplatin (FOLFOX) or irinotecan
(FOLFIRI) causes histological liver injury and increases postoperative morbidity and …

In this study, some pyrazolone‐based Schiff base derivatives 2a‐e (except 2a) were
synthesized for the first time and structurally illuminated by some spectroscopic techniques …